American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$234M |
| 2 |
Unilever
UL
|
+$230M |
| 3 |
Sysco
SYY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$206M |
| 5 |
Sea Limited
SE
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$395M |
| 2 |
Boston Scientific
BSX
|
+$331M |
| 3 |
Illumina
ILMN
|
+$318M |
| 4 |
Alibaba
BABA
|
+$296M |
| 5 |
SBA Communications
SBAC
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Financials | 14.89% |
| 3 | Healthcare | 14.13% |
| 4 | Consumer Discretionary | 14.08% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Halozyme
HALO
$11.4B
| $19M | 0.01% |
445,237
+12,150
| +3% | +$437K |
|
627
Fox Class A
FOXA
$27.5B
| $18.9M | 0.01% |
648,078
+473,578
| +271% | +$13.2M |
|
628
Southern Company
SO
$107B
| $18.9M | 0.01% |
307,214
-134,614
| -30% | -$8.09M |
|
629
Omega Healthcare
OHI
$13.9B
| $18.7M | 0.01% |
513,510
+3,820
| +0.7% | +$129K |
|
|
FOLD
630
DELISTED
Amicus Therapeutics
FOLD
| $18.6M | 0.01% |
807,412
-905
| -0.1% | -$18.5K |
|
631
TD Synnex
SNX
$20.4B
| $18.6M | 0.01% |
228,587
-347,289
| -60% | -$26.5M |
|
632
Fidelity National Financial
FNF
$13.1B
| $18.6M | 0.01% |
495,076
+484,296
| +4,493% | +$16.3M |
|
633
Quanta Services
PWR
$101B
| $18.6M | 0.01% |
257,794
+131,991
| +105% | +$8.7M |
|
634
Teva Pharmaceuticals
TEVA
$42.6B
| $18.2M | 0.01% |
1,882,313
+32,560
| +2% | +$312K |
|
|
PMT
635
PennyMac Mortgage Investment
PMT
$828M
| $18.1M | 0.01% |
1,029,988
+75,763
| +8% | +$1.28M |
|
636
Invesco
IVZ
$14.3B
| $18.1M | 0.01% |
1,037,194
-563,922
| -35% | -$8.67M |
|
637
Kroger
KR
$35.1B
| $18M | 0.01% |
568,231
-501,893
| -47% | -$16.3M |
|
|
SAGE
638
DELISTED
Sage Therapeutics
SAGE
| $18M | 0.01% |
208,159
-11,845
| -5% | -$873K |
|
639
Alaska Air
ALK
$5.3B
| $18M | 0.01% |
346,186
+55,904
| +19% | +$2.51M |
|
640
BridgeBio Pharma
BBIO
$15.9B
| $18M | 0.01% |
252,865
+29,898
| +13% | +$1.44M |
|
641
East-West Bancorp
EWBC
$18.6B
| $18M | 0.01% |
354,351
+219,757
| +163% | +$9.33M |
|
|
AMWD
642
DELISTED
American Woodmark
AMWD
| $17.5M | 0.01% |
+186,558
| New | +$17M |
|
643
Descartes Systems
DSGX
$6.62B
| $17.5M | 0.01% |
299,014
-40,200
| -12% | -$2.28M |
|
644
Iron Mountain
IRM
$37.7B
| $17.3M | 0.01% |
587,964
+422,757
| +256% | +$11.7M |
|
645
Unifirst Corp
UNF
$5.21B
| $17.3M | 0.01% |
81,879
-93,980
| -53% | -$17.9M |
|
|
DOC
646
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $17.3M | 0.01% |
972,086
-147,963
| -13% | -$2.65M |
|
647
HCA Healthcare
HCA
$89.1B
| $17.3M | 0.01% |
104,901
+99,744
| +1,934% | +$14.6M |
|
648
Seagate
STX
$209B
| $17.2M | 0.01% |
277,283
-46,372
| -14% | -$2.61M |
|
649
Onto Innovation
ONTO
$20.6B
| $17.2M | 0.01% |
+362,439
| New | +$14.5M |
|
|
EVBG
650
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $17.2M | 0.01% |
115,136
-37,939
| -25% | -$4.85M |
|
Similar funds
American Century Companies's Q4 2020 Portfolio in Review
As of Q4 2020, American Century Companies held 2,076 positions worth $128B, up 14% from $113B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
American Century Companies's Q4 2020 filing shows 276 new, 1,105 increased, 539 reduced and 122 closed positions. Its largest new stake was Crane NXT: 2,746,264 shares worth $74.1M. The largest sale was iShares Russell 1000 Value ETF, an estimated $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2020 buy was Crane NXT: 2,746,264 shares worth $74.1M.
- American Century Companies added most to Colgate-Palmolive in Q4 2020, an estimated $234M increase.
- American Century Companies's biggest Q4 2020 reduction was iShares Russell 1000 Value ETF, cutting an estimated $395M.
- American Century Companies fully exited Wells Fargo 7.5% Non Cumv Perp Conv in Q4 2020, selling an estimated $154M.
- American Century Companies's ten largest holdings make up 22% of its $128B portfolio in Q4 2020.
- American Century Companies opened 276 new positions and closed 122 in Q4 2020.
- American Century Companies's portfolio value rose 14% quarter-over-quarter to $128B.
Based on American Century Companies's 13F filing for Q4 2020, filed 12 Feb 2021.